RNA-Seq investigation and in vivo study the effect of strontium ranelate on ovariectomized rat via the involvement of ROCK1
- 30 January 2018
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup1) , 629-641
Abstract
Strontium ranelate (SrR) is an anti-osteoporosis drug with excellent osteogenic and angiogenic capacity. In this study, we aimed to investigate the osteogenesis and angiogenesis effects of SrR and the underlying mechanism involved. RNA-Seq was conducted to examine the effects of SrR on gene expression in ovariectomy rat bone marrow mesenchymal stem cells (OVX-rBMSCs). To validate the different expressed gene in vitro, the effects of gene interference and overexpression in osteogenic induction environment of OVX-rBMSCs and in primary osteoblasts were studied. RNA-Seq showed that ROCK1 significantly increased after SrR treatment in OVX-rBMSCs, and further validated by real-time PCR and western blotting. Overexpression of ROCK1 promoted osteogenic differentiation of OVX-rBMSCs and induced cell viability and inhibited apoptosis of primary osteoblasts, which was reversed by inhibition of ROCK1 by RNA interference or ROCK1 inhibitor (Y-27632) after SrR treatment. Furthermore, the SrR was loaded on nano-structured hydroxyapatite (nano-HAp) particulates to promote osteogenesis and angiogenesis in repairing of the femoral condyle bone defect using ovariectomy rat model. Taken together, ROCK1 is one of the targets that SrR promotes the osteogenic differentiation of OVX-rBMSCs and cell viability of primary osteoblasts, the nano-HAp particles could act as carriers for SrR to repair bone defects.Keywords
Funding Information
- National Natural Science Foundation of China (81470714, 31400825, 81672134)
- Science and Technology Commission of Shanghai Municipality (15410722600, 16140903900, 5441905300, 17510710800)
- Research Project of Shanghai Stomatological Hospital (SSDC-2017-01)
- Shanghai Municipal Commission of Health and Family Planning (201540369, 17PJD030)
- Shanghai Jiao Tong University (LYZY-0082)
- Shanghai Jiao Tong University (15ZH2012)
This publication has 37 references indexed in Scilit:
- Recent advances in the pathogenesis and treatment of osteoporosisClinical Medicine, 2015
- A review on strontium ranelate long-term antifracture efficacy in the treatment of postmenopausal osteoporosisTherapeutic Advances in Musculoskeletal Disease, 2013
- Strontium substituted hydroxyapatite porous microspheres: Surfactant-free hydrothermal synthesis, enhanced biological response and sustained drug releaseChemical Engineering Journal, 2013
- Essential Role of Nuclear Factor of Activated T Cells (NFAT)-mediated Wnt Signaling in Osteoblast Differentiation Induced by Strontium RanelateJournal of Biological Chemistry, 2010
- Calcium sensing receptor‐dependent and receptor‐independent activation of osteoblast replication and survival by strontium ranelateJournal of Cellular and Molecular Medicine, 2009
- Strontium Promotes Osteogenic Differentiation of Mesenchymal Stem Cells Through the Ras/MAPK Signaling PathwayCellular Physiology and Biochemistry, 2009
- Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosisOsteoporosis International, 2009
- Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin responseOsteoporosis International, 2008
- Strontium ranelate promotes osteoblastic cell replication through at least two different mechanismsBone, 2008
- Automated osteoporosis risk assessment by dentists: A new pathway to diagnosisBone, 2007